Frederic D. Sweeney

Frederic D. Sweeney has held various senior roles in the field of life sciences and diagnostics. Currently serving as the Director, President, and CEO at VedaBio, Frederic D. leads a team of industry experts in pushing the boundaries of molecular detection. Previously, Frederic D. also held positions at OMX Ventures, Qvella Corporation, CTRL Therapeutics, MeMed, Northern Biologics, Banyan Biomarkers Inc, bioMerieux, and T2 Biosystems, showcasing their extensive experience in strategic development, corporate leadership, and venture capital investments. With a strong academic background, including a PhD in Molecular and Medical Genetics, Frederic D. Sweeney continues to make significant contributions to the advancement of healthcare and diagnostics.